A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Joseph Health Care London
London, Ontario, Canada
- Mount Sinai Hospital
Toronto, Ontario, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Royal Free Hospital
London, United Kingdom
- Arthritis Associates of Southern California
Los Angeles, California, United States
- University of California- Los Angeles
Los Angeles, California, United States
- Stanford University
Redwood City, California, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Northwestern University
Chicago, Illinois, United States
- Boston University
Boston, Massachusetts, United States
- Harvard Mass General
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Rutgers University Clinical Research Center
New Brunswick, New Jersey, United States
- Steffens Scleroderma Center
Albany, New York, United States
- Northwell Health
Great Neck, New York, United States
- Columbia University
New York, New York, United States
- Hospital for Special Surgery
New York, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Ohio State University Medical Center
Columbus, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas Health Center at Houston
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Swedish Health Services
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2014
- Primary completion
- 12 Sept 2018
- Completion
- 17 Oct 2018
- Last update posted
- 17 Feb 2020
- Registered enrollment
- 88
- Registry id
- NCT02161406
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.